Table 2.
Response Rate (Reflux Symptom Index) at 8-week and 16-week Follow-up
FAS | BID group (n = 50) | QD group (n = 51) | COR (95% CI) | P-valuea |
---|---|---|---|---|
Primary outcome | ||||
16 weeks RSI responder | 16 (32.0) | 19 (37.3) | 1.05 (0.00-2.15) | 0.541 |
Secondary outcome | ||||
8 weeks RSI responder | 13 (26.0) | 15 (29.4) | 0.92 (0.00-2.01) | 0.433 |
PPS | BID group (n = 37) | QD group (n = 38) | COR (95% CI) | P-valuea |
---|---|---|---|---|
Primary outcome | ||||
16 weeks RSI responder | 13 (35.1) | 14 (36.8) | 0.83 (0.00-1.93) | 0.460 |
Secondary outcome | ||||
8 weeks RSI responder | 10 (27.0) | 11 (28.9) | 0.82 (0.00-2.02) | 0.465 |
aLeft tail test for one-sided alpha 0.05.
FAS, full analysis set; BID, twice daily; QD, once daily; COR, common odds ratio; RSI, Reflux Symptom Index; PPS, per-protocol set.